Evidence map›Paper›PMID 41588045›Full record

ArticleScientific reports2026

Differential mechanisms of SARS-CoV-2 inactivation by anionic surfactants: a comparative study of fatty acid salts and synthetic surfactants.

Akima Yamamoto, Yuna Iseki, Abeer Mohamed Abdelfattah Elsayed, Takayoshi Kawahara, Isamu Akiba, Tomoyuki Akita, Junko Tanaka, Takemasa Sakaguchi, Akifumi Higashiura

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akima YamamotoDepartment of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Yuna IsekiDepartment of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Abeer Mohamed Abdelfattah ElsayedDepartment of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Takayoshi KawaharaResearch and Development Department, Shabondama Soap Co., Ltd., 2- 23-1 Minami-futajima, Wakamatsu-ku, Kitakyushu, 808-0103, Japan.
Isamu AkibaDepartment of Chemistry and Biochemistry, The University of Kitakyushu, 1-1 Hibikino, Wakamatsu-ku, Kitakyushu, 808-0135, Japan.
Tomoyuki AkitaDepartment of Epidemiology, Infectious Disease Control, and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Junko TanakaDepartment of Epidemiology, Infectious Disease Control, and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Takemasa Sakaguchi *Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. tsaka@hiroshima-u.ac.jp.
Akifumi Higashiura *Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. ahigashiura@hiroshima-u.ac.jp.

Funding

Japan Agency for Medical Research and Development JP20he0622011
6 · The paper itself

Abstract

Despite advances in COVID-19 vaccines and antivirals, SARS-CoV-2 remains a significant public-health threat. While handwashing helps prevent infection, the anti-SARS-CoV-2 activity of anionic surfactants in hand soaps has not been systematically evaluated. In this study, we compared five surfactants: potassium oleate (C18:1-K), potassium myristate (C14:0-K), potassium laurate (C12:0-K), sodium laureth sulfate (SLES), and sodium dodecyl sulfate (SDS). Viral infectivity assays demonstrated that C18:1-K exhibited remarkable efficacy, reducing SARS-CoV-2 infectivity by more than 10⁵-fold at a concentration of 1 mM. In contrast, SDS achieved only about a 10¹-fold reduction, and both SLES and C12:0-K showed minimal activity. Isothermal titration calorimetry revealed that C18:1-K-virus interactions exhibited a positive enthalpy change (ΔH), indicating endothermic hydrophobic interactions with viral-envelope lipids-contrasting with the results observed for influenza virus. By contrast, SDS and C12:0-K interactions showed negative ΔH values, suggesting exothermic electrostatic interactions with viral surface proteins. Transmission electron microscopy revealed extensive "rupture" images of viral particles after treatment with SDS or C12:0-K, whereas no such image was observed with C18:1-K. All surfactants induced concentration-dependent viral aggregation, suggesting that aggregation also contributes to viral inactivation. Among the surfactants tested, C18:1-K, which demonstrated the highest antiviral activity, also had the lowest critical micelle concentration, suggesting that hydrophobic interactions become pronounced above this threshold. These findings suggest that the inactivation mechanisms of SARS-CoV-2 vary according to the physicochemical properties of the surfactants. Surfactants with strong hydrophobic interaction capabilities may exert superior antiviral effects, offering insights for the rational design of effective disinfectants.

Indexed as

Antiviral AgentsFatty AcidsSARS-CoV-2Surface-Active AgentsVirus InactivationAnimalsAnionsChlorocebus aethiopsHumansHydrophobic and Hydrophilic InteractionsSodium Dodecyl SulfateVero CellsAnionsAntiviral AgentsFatty AcidsSodium Dodecyl SulfateSurface-Active AgentsCritical micelle concentrationHydrophobic interactionIsothermal titration calorimetryPotassium oleateSurfactantsTransmission electron microscopyVirus inactivation

Identifiers

PMID41588045
PMCPMC12909891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.